{
    "organizations": [],
    "uuid": "5b73c4994888daeb3bacef587c54607055c29254",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-galmed-pharmaceuticals-announces-p/brief-galmed-pharmaceuticals-announces-pricing-of-6-mln-registered-direct-offering-idUSASC09UMU",
    "ord_in_thread": 0,
    "title": "BRIEF-Galmed Pharmaceuticals Announces Pricing Of $6 Mln Registered Direct Offering",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 3 (Reuters) - Galmed Pharmaceuticals Ltd:\n* ANNOUNCES PRICING OF $6.0 MILLION REGISTERED DIRECT OFFERING\n* ENTERED INTO SECURITIES PURCHASE AGREEMENT WITH BIOTECHNOLOGY VALUE FUND, L.P. AND CERTAIN OF ITS AFFILIATES\n* DEAL TO BUY, SELL 1 MILLION SHARES, WARRANTS TO PURCHASE 1 MILLION SHARES, FOR $6.00/SHARE, RELATED WARRANT Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-03T19:36:00.000+03:00",
    "crawled": "2018-04-04T12:34:38.029+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "galmed",
        "pharmaceutical",
        "ltd",
        "announces",
        "pricing",
        "million",
        "registered",
        "direct",
        "offering",
        "entered",
        "security",
        "purchase",
        "agreement",
        "biotechnology",
        "value",
        "fund",
        "certain",
        "affiliate",
        "deal",
        "buy",
        "sell",
        "million",
        "share",
        "warrant",
        "purchase",
        "million",
        "share",
        "related",
        "warrant",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}